Mastectomy for management of breast cancer in Ibadan, Nigeria

BMC Surgery

Volumn 13, Issue 1, 2013, Pages

  Ogundiran, Temidayo O ^a,b   Ayandipo, Omobolaji O ^b   Ademola, Adeyinka F ^a,b   Adebamowo, Clement A ^c,d  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Mastectomy; Nigeria

Indexed keywords

ADULT; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; DEVELOPING COUNTRY; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; MALE; MASTECTOMY; MIDDLE AGED; NIGERIA; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; ARTICLE; BREAST TUMOR; PAGET NIPPLE DISEASE; POSTOPERATIVE COMPLICATION; STATISTICS;

ADULT; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; DEVELOPING COUNTRIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NIGERIA; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84890410293     PISSN: None     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/1471-2482-13-59     Document Type: Article

References (43)

1. Holland-Frei Cancer Medicine 6 Hamilton, Ontario, Canada: BC Decker, Kufe DW, Pollock RE, Weichselbaum RR, 6 2003
2. The changing face of mastectomy (from mutilation to Aid to breast reconstruction). Zurrida S, Bassi F, Arnone P, et al. Int J Surg Oncol 2011 2011 980158 22312537
3. Breast cancer in Nigeria. Adebamowo CA, Ajayi OO, West Afr J Med 2000 19 179 191 11126081
4. Breast cancer management in low resource countries (LRCs): consensus statement from the breast health global initiative. El Saghir NS, Adebamowo CA, Anderson BO, et al. Breast 2011 20 Suppl 2 3 S11 21392996
5. Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity. Broadwater JR, Edwards MJ, Kuglen C, Hortobagyi GN, Ames FC, Balch CM, Ann Surg 1991 213 126 129 10.1097/00000658-199102000- 00006 1992938
6. Inappropriate Halsted mastectomy and patient volume in Italian hospitals. Grilli R, Mainini F, Penna A, et al. Am J Public Health 1993 83 1762 1764 10.2105/AJPH.83.12.1762 8259814 (Pubitemid 24009514)
7. Surgical management of breast cancer in a small peripheral New Zealand hospital. Lee DW, Vallance S, ANZ J Surg 2006 76 1060 1063 10.1111/j.1445-2197. 2006.03940.x 17199690 (Pubitemid 44949028)
8. Morbidity and mortality following breast cancer surgery in women: National benchmarks for standards of care. El-Tamer MB, Ward BM, Schifftner T, Neumayer L, Khuri S, Henderson W, Ann Surg 2007 245 665 671 10.1097/01.sla. 0000245833.48399.9a 17457156 (Pubitemid 46684093)
9. Acceptance and adherence to treatment among breast cancer patients in Eastern Nigeria. Anyanwu SN, Egwuonwu OA, Ihekwoaba EC, Breast 2011 20 Suppl 2 51 S53 21295480
10. Case-controlled study of the epidemiological risk factors for breast cancer in Nigeria. Adebamowo CA, Adekunle OO, Br J Surg 1999 86 665 668 10.1046/j.1365-2168.1999.01117.x 10361191 (Pubitemid 29248362)
11. Comparison of four-day and ten-day post- mastectomy passive drainage in Accra, Ghana. Clegg-Lamptey JN, Dakubo JC, Hodasi WM, East Afr Med J 2007 84 561 565 18402307
12. A study of breast cancer in korle bu teaching hospital: assessing the impact of health education. Clegg-Lamptey J, Hodasi W, Ghana Med J 2007 41 72 77 17925846
13. Socio-demographic factors and reasons associated with delay in breast cancer presentation: a study in Nigerian women. Ibrahim NA, Oludara MA, Breast 2012 21 416 418 10.1016/j.breast.2012.02.006 22381153
14. Breast cancer before age 40 years. Anders CK, Johnson R, Litton J, Phillips M, Bleyer A, Semin Oncol 2009 36 237 249 10.1053/j.seminoncol.2009.03. 001 19460581
15. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Bird PA, Hill AG, Houssami N, Ann Surg Oncol 2008 15 1983 1988 10.1245/s10434-008-9900-7 18408976
16. Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE, Breast Cancer Res Treat 2008 110 183 188 10.1007/s10549-007-9694-5 17674190 (Pubitemid 351793859)
17. Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. Gukas ID, Jennings BA, Mandong BM, et al. West Afr J Med 2005 24 209 213 16276696
18. Breast cancer in Nigeria and Finland: Epidemiological, clinical and histological comparison. Ikpatt OF, Kuopio T, Ndoma-Egba R, Collan Y, Anticancer Res 2002 22 3005 3012 12530033 (Pubitemid 36069350)
19. Variability of immunohistochemical reactivity on stored paraffin slides. Bertheau P, Cazals-Hatem D, Meignin V, et al. J Clin Pathol 1998 51 370 374 10.1136/jcp.51.5.370 9708203 (Pubitemid 28289123)
20. Variability of immunohistochemical reactivity on stored paraffin slides. Olapade-Olaopa EO, MacKay EH, Habib FK, J Clin Pathol 1998 51 943 (Pubitemid 29005302)
21. Breast cancer clinic at Groote Schuur Hospital. Murray E, AORTIC Newsletter South Africa: AORTIC 2005 10 1
22. Histopathology of breast cancer among African-American women. Middleton LP, Chen V, Perkins GH, Pinn V, Page D, Cancer 2003 97 253 257 10.1002/cncr.11021 12491489 (Pubitemid 36033847)
23. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. Nichols HB, Trentham-Dietz A, Love RR, et al. Cancer Epidemiol Biomarkers Prev 2005 14 41 47 15668474 (Pubitemid 40165281)
24. Neoadjuvant chemotherapy for locally advanced premenopausal breast cancer in Nigerian women: early experience. Anyanwu SN, Nwose P, Ihekwoaba E, Mbaeri AT, Chukwuanukwu TO, Niger J Clin Pract 2010 13 215 217 20499759
25. Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania. Schwartz GF, Hortobagyi GN, Cancer 2004 100 2512 2532 10.1002/cncr.20298 15197792 (Pubitemid 38715755)
26. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. Muss HB, Woolf S, Berry D, et al. JAMA 2005 293 1073 1081 10.1001/jama.293.9.1073 15741529 (Pubitemid 40300281)
27. Locoregional recurrence of breast conserving surgery after preoperative chemotherapy in korean women with locally advanced breast cancer. Lee S, Kim SW, Kim SK, et al. J Breast Cancer 2011 14 289 295 10.4048/jbc.2011.14.4.289 22323915
28. Options in breast cancer local therapy: who gets what? Jatol I, World J Surg 2012 36 1498 1502 10.1007/s00268-012-1530-3 22382769
29. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Litiere S, Werutsky G, Fentiman IS, et al. Lancet Oncol 2012 13 412 419 10.1016/S1470-2045(12)70042-6 22373563
30. Blood transfusions in breast cancer patients undergoing mastectomy: Possible importance of timing. Pysz M, J Surg Oncol 2000 75 258 263 10.1002/1096-9098(200012)75:4<258::AID-JSO6>3.0.CO;2-I 11135267
31. Postoperative changes related to intraoperative blood transfusions. Aslan S, Akinci M, Cetin B, Cakmak H, Pirhan Y, Cetin A, Bratisl Lek Listy 2011 112 575 578 21954543
32. Wound infection and infection-promoting factors in breast cancer surgery-a prospective multicenter study on quality control. Leinung S, Schonfelder M, Winzer KJ, et al. Zentralbl Chir 2005 130 16 20 10.1055/s-2005-836293 15717235 (Pubitemid 40332847)
33. Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. The Danish breast cancer cooperative group. Eickhoff JH, Andersen J, Laybourn C, Br J Surg 1991 78 1358 1361 10.1002/bjs.1800781129 1760703
34. Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. Akyol AM, Galloway DJ, George WD, Br J Surg 1992 79 470
35. Audit of blood transfusion in elective breast cancer surgery-do we need to group and save pre-operatively? Malik H, Bishop H, Winstanley J, Ann R Coll Surg Engl 2008 90 472 473 10.1308/003588408X301091 18765025
36. Closed suction drainage versus closed simple drainage in the management of modified radical mastectomy wounds. Ezeome ER, Adebamowo CA, S Afr Med J 2008 98 712 715 19113053
37. Economic impact of reducing hospitalization for mastectomy patients. Edwards MJ, Broadwater JR, Bell JL, Ames FC, Balch CM, Ann Surg 1988 208 330 336 10.1097/00000658-198809000-00010 3421757
38. Randomized clinical trial of no wound drains and early discharge in the treatment of women with breast cancer. Purushotham AD, McLatchie E, Young D, et al. Br J Surg 2002 89 286 292 10.1046/j.0007-1323.2001.02031.x 11872051 (Pubitemid 34227025)
39. Early hospital discharge following mastectomy. Tarazi R, Esselstyn CB Jr, Kuivila T, Hardesty I, Cleve Clin Q 1984 51 579 584 10.3949/ccjm.51.4.579 6525758 (Pubitemid 15142475)
40. Non-tumour morbidity and mortality after modified radical mastectomy. Wedgwood KR, Benson EA, Ann R Coll Surg Engl 1992 74 314 317 1416701
41. Comparing scalpel, electrocautery and ultrasonic dissector effects: the impact on wound complications and pro-inflammatory cytokine levels in wound fluid from mastectomy patients. Yilmaz KB, Dogan L, Nalbant H, et al. J Breast Cancer 2011 14 58 63 10.4048/jbc.2011.14.1.58 21847396
42. Pathophysiology of seroma in breast cancer. Kuroi K, Shimozuma K, Taguchi T, et al. Breast Cancer 2005 12 288 293 10.2325/jbcs.12.288 16286909
43. Survival following treatment of primary breast cancer in eastern Nigeria. Anyanwu SN, East Afr Med J 2000 77 539 543 12862121 (Pubitemid 33249588)